Lineage Cell Therapeutics (LCTX) Current Deferred Revenue (2010 - 2026)
Lineage Cell Therapeutics' Current Deferred Revenue was $1.68 million in Q2 2026, down 68.1% from $5.26 million a year earlier and down 2.2% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Current Deferred Revenue (2010 - 2026) Analysis & Trends
At the end of FY2025, Current Deferred Revenue at Lineage Cell Therapeutics came in at $3.33 million, down 54.9% from FY2024.
- Current Deferred Revenue shows a five-year compound annual growth rate of 76.8% (FY2020 to FY2025).
- In earlier years, Current Deferred Revenue was $7.39 million in FY2024 (-31.6%), $10.81 million in FY2023 (+14.7%), $9.42 million in FY2022 (-48.0%) and $18.12 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Current Deferred Revenue since Q3 2021.
- Compared with a year earlier, Current Deferred Revenue has declined for ten straight quarters, with an average decline of 46.9% over the last eight quarters.
- The best year-over-year quarter for Current Deferred Revenue over five years was Q4 2023 (growth of 14.7%); the worst was Q1 2026 (a decline of 75.2%).
- Per Business Quant data, LCTX's Current Deferred Revenue in the three quarters before Q2 2026 was $1.72 million (Q1 2026), $3.33 million (Q4 2025) and $3.77 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Lineage Cell Therapeutics | 242.79 Mn | 41.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.68 Mn |
| Mar 31, 2026 | 1.72 Mn |
| Dec 31, 2025 | 3.33 Mn |
| Sep 30, 2025 | 3.77 Mn |
| Jun 30, 2025 | 5.26 Mn |
| Mar 31, 2025 | 6.93 Mn |
| Dec 31, 2024 | 7.39 Mn |
| Sep 30, 2024 | 8.25 Mn |
| Jun 30, 2024 | 9.14 Mn |
| Mar 31, 2024 | 10.11 Mn |
| Dec 31, 2023 | 10.81 Mn |
| Sep 30, 2023 | 9.92 Mn |
| Jun 30, 2023 | 10.38 Mn |
| Mar 31, 2023 | 11.01 Mn |
| Dec 31, 2022 | 9.42 Mn |
| Sep 30, 2022 | 12.36 Mn |
| Jun 30, 2022 | 15.79 Mn |
| Mar 31, 2022 | 14.89 Mn |
| Dec 31, 2021 | 18.12 Mn |
| Sep 30, 2021 | 975,000.00 |
API Access
Lineage Cell Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();